Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): Single-agent therapeutic window study in relapsed AML-Reference-Cited by-同舟云学术

Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): Single-agent therapeutic window study in relapsed AML

Published:2006 Issue:5 Volume:47 Page:539-542
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Kaspers G.J.L.,Reinhardt D.,Fleischhack G.,Armendariz H.,Stark B.,Zwaan C.M.,Zimmermann M.,Creutzig U.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference18 articles.

1. . Acute myeloid leukemia in children and adolescents. In: , , , editors. Textbook of malignant haematology. London: Martin Dunitz; 2005. pp 617–632.

2. Role of Folylpolyglutamate Synthetase and Folylpolyglutamate Hydrolase in Methotrexate Accumulation and Polyglutamylation in Childhood Leukemia

3. Classification OfEx VivoMethotrexate Resistance In Acute Lymphoblastic and Myeloid Leukaemia

4. A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia

5. Anti-folate resistance in leukemia: treatment with “high-dose” methotrexate and citrovorum factor

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group;Journal of Clinical Oncology;2013-02-10

2. Drug Resistance in Childhood Acute Myeloid Leukemia;Current Pharmaceutical Biotechnology;2007-04-01

3. Current Awareness in Hematological Oncology;Hematological Oncology;2007